JP2020508648A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508648A5 JP2020508648A5 JP2019542464A JP2019542464A JP2020508648A5 JP 2020508648 A5 JP2020508648 A5 JP 2020508648A5 JP 2019542464 A JP2019542464 A JP 2019542464A JP 2019542464 A JP2019542464 A JP 2019542464A JP 2020508648 A5 JP2020508648 A5 JP 2020508648A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- aav
- hair cell
- associated virus
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000002768 hair cell Anatomy 0.000 claims description 16
- 241000702421 Dependoparvovirus Species 0.000 claims description 12
- 210000003027 ear inner Anatomy 0.000 claims description 12
- 230000008685 targeting Effects 0.000 claims description 12
- 102100024110 LHFPL tetraspan subfamily member 5 protein Human genes 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 206010011878 Deafness Diseases 0.000 claims description 6
- 102100037931 Harmonin Human genes 0.000 claims description 6
- 101710132730 Harmonin Proteins 0.000 claims description 6
- 102100036382 Protocadherin-15 Human genes 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 208000014769 Usher Syndromes Diseases 0.000 claims description 5
- 102100031809 Espin Human genes 0.000 claims description 4
- 101710118108 Espin Proteins 0.000 claims description 4
- 101000981537 Homo sapiens LHFPL tetraspan subfamily member 5 protein Proteins 0.000 claims description 4
- 101000591234 Homo sapiens Phosphatidylinositol phosphatase PTPRQ Proteins 0.000 claims description 4
- 101001072259 Homo sapiens Protocadherin-15 Proteins 0.000 claims description 4
- 101000591236 Homo sapiens Receptor-type tyrosine-protein phosphatase R Proteins 0.000 claims description 4
- 101150050795 LHFPL5 gene Proteins 0.000 claims description 4
- 102100034101 Receptor-type tyrosine-protein phosphatase R Human genes 0.000 claims description 4
- 230000010370 hearing loss Effects 0.000 claims description 4
- 231100000888 hearing loss Toxicity 0.000 claims description 4
- 208000016354 hearing loss disease Diseases 0.000 claims description 4
- 102100032216 Calcium and integrin-binding protein 1 Human genes 0.000 claims description 2
- 101000943475 Homo sapiens Calcium and integrin-binding protein 1 Proteins 0.000 claims description 2
- 101000801040 Homo sapiens Transmembrane channel-like protein 1 Proteins 0.000 claims description 2
- 101000638069 Homo sapiens Transmembrane channel-like protein 2 Proteins 0.000 claims description 2
- 101100428000 Homo sapiens USH1G gene Proteins 0.000 claims description 2
- 206010048865 Hypoacusis Diseases 0.000 claims description 2
- 102000003505 Myosin Human genes 0.000 claims description 2
- 108060008487 Myosin Proteins 0.000 claims description 2
- 101710157841 Protocadherin-15 Proteins 0.000 claims description 2
- 102100033690 Transmembrane channel-like protein 1 Human genes 0.000 claims description 2
- 102100032054 Transmembrane channel-like protein 2 Human genes 0.000 claims description 2
- 201000008616 Usher syndrome type 1 Diseases 0.000 claims description 2
- 102100037929 Usher syndrome type-1G protein Human genes 0.000 claims description 2
- 210000000234 capsid Anatomy 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims description 2
- 230000006870 function Effects 0.000 claims description 2
- 210000000067 inner hair cell Anatomy 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims description 2
- 239000002157 polynucleotide Substances 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 238000000034 method Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 2
- 102100022509 Cadherin-23 Human genes 0.000 description 1
- 101710196902 Cadherin-23 Proteins 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023000088A JP7601916B2 (ja) | 2017-02-06 | 2023-01-04 | 蝸牛および前庭細胞に核酸を送達するための物質および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762455197P | 2017-02-06 | 2017-02-06 | |
| US62/455,197 | 2017-02-06 | ||
| PCT/US2018/017104 WO2018145111A1 (en) | 2017-02-06 | 2018-02-06 | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000088A Division JP7601916B2 (ja) | 2017-02-06 | 2023-01-04 | 蝸牛および前庭細胞に核酸を送達するための物質および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508648A JP2020508648A (ja) | 2020-03-26 |
| JP2020508648A5 true JP2020508648A5 (https=) | 2021-03-18 |
Family
ID=63040112
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542464A Withdrawn JP2020508648A (ja) | 2017-02-06 | 2018-02-06 | 蝸牛および前庭細胞に核酸を送達するための物質および方法 |
| JP2023000088A Active JP7601916B2 (ja) | 2017-02-06 | 2023-01-04 | 蝸牛および前庭細胞に核酸を送達するための物質および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000088A Active JP7601916B2 (ja) | 2017-02-06 | 2023-01-04 | 蝸牛および前庭細胞に核酸を送達するための物質および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11730827B2 (https=) |
| EP (1) | EP3576696A4 (https=) |
| JP (2) | JP2020508648A (https=) |
| CN (1) | CN111698975A (https=) |
| AU (2) | AU2018215785B2 (https=) |
| CA (1) | CA3052704A1 (https=) |
| WO (1) | WO2018145111A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3510161A4 (en) | 2016-08-23 | 2020-04-22 | Akouos, Inc. | COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON |
| DE102018103924A1 (de) * | 2018-02-21 | 2019-08-22 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Gentherapeutische Behandlung von Schwerhörigkeit |
| EP3762040A4 (en) | 2018-03-05 | 2022-01-05 | Children's Medical Center Corporation | COMPOSITIONS AND METHODS OF ADMINISTRATION OF NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS |
| CN112703016B (zh) | 2018-04-27 | 2024-11-22 | 分贝治疗公司 | 肌球蛋白15启动子及其用途 |
| US11660353B2 (en) | 2018-04-27 | 2023-05-30 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| EP3856227A4 (en) | 2018-09-27 | 2022-07-06 | Akouos, Inc. | METHODS OF TREATMENT OF AUDITORY NEUROPATHY SPECTRUM DISEASE |
| WO2020077295A1 (en) | 2018-10-11 | 2020-04-16 | Decibel Therapeutics, Inc. | Aav1 vectors and uses thereof for treatment of otic indications |
| EP3897679A1 (en) * | 2018-12-21 | 2021-10-27 | Wade Wei-De Chien | Adeno-associated viruses and their uses for inner ear therapy |
| CA3129422A1 (en) | 2019-02-08 | 2020-08-13 | Decibel Therapeutics, Inc. | Myosin 15 promoters and uses thereof |
| EP3921032A4 (en) * | 2019-02-08 | 2022-11-30 | Decibel Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS |
| EP3959324B1 (en) * | 2019-04-26 | 2025-09-17 | President and Fellows of Harvard College | Aav vectors encoding mini-pcdh15 and uses thereof |
| JP2022530457A (ja) | 2019-04-26 | 2022-06-29 | サンガモ セラピューティクス， インコーポレイテッド | 遺伝子操作ａａｖ |
| EP4007814A1 (en) * | 2019-07-26 | 2022-06-08 | Akouos, Inc. | Methods of treating hearing loss using a secreted target protein |
| KR20220130093A (ko) | 2019-10-30 | 2022-09-26 | 데시벨 테라퓨틱스, 인크. | 오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 조성물 및 방법 |
| EP4055175A4 (en) * | 2019-11-04 | 2023-11-29 | Decibel Therapeutics, Inc. | Cochlear inner hair cell promoters and uses thereof |
| TWI902721B (zh) * | 2019-11-04 | 2025-11-01 | 美商迪賽博治療公司 | 前庭支持細胞啟動子及其用途 |
| WO2021150850A1 (en) * | 2020-01-24 | 2021-07-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Svcs. | Adeno-associated viruses and their uses for inner ear therapy |
| KR20220157944A (ko) | 2020-02-21 | 2022-11-29 | 아카우오스, 인크. | 인간 대상체에서 비-연령-연관 청각 장애를 치료하기 위한 조성물 및 방법 |
| EP4262882A1 (en) * | 2020-12-18 | 2023-10-25 | Institut Pasteur | Gene therapy for treating usher syndrome |
| CN114762733B (zh) * | 2021-01-15 | 2025-03-18 | 中国科学院脑科学与智能技术卓越创新中心 | 耳蜗外毛细胞特异性顺式调节元件及其应用 |
| KR102751019B1 (ko) * | 2021-03-03 | 2025-01-09 | 연세대학교 산학협력단 | Kcnq4 유전자 교정용 가이드 rna 및 이를 포함하는 난청 치료용 조성물 |
| WO2023147383A1 (en) | 2022-01-25 | 2023-08-03 | Bridgebio Services Inc. | Gene therapy for genetic hearing loss |
| CN121263526A (zh) * | 2023-05-23 | 2026-01-02 | 苏州星奥拓维生物技术有限公司 | 耳蜗毛细胞特异性启动子及其用途 |
| CN119061007A (zh) * | 2023-06-02 | 2024-12-03 | 苏州星奥拓维生物技术有限公司 | 耳蜗支持细胞基因治疗和再生的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8673634B2 (en) * | 2003-11-13 | 2014-03-18 | Massachusetts Eye & Ear Infirmary | Method for the treatment of hearing loss |
| WO2011075838A1 (en) * | 2009-12-21 | 2011-06-30 | Audigen Inc. | Method of treating or preventing hearing loss |
| KR100990160B1 (ko) * | 2010-03-15 | 2010-10-29 | 도태환 | 기전력 안정화 영구자석 발전기 |
| CN106232618A (zh) * | 2013-10-11 | 2016-12-14 | 马萨诸塞眼科耳科诊所 | 预测祖先病毒序列的方法及其用途 |
| JP7103750B2 (ja) * | 2013-12-12 | 2022-07-20 | ザ・ブロード・インスティテュート・インコーポレイテッド | ゲノム編集のためのＣＲＩＳＰＲ－Ｃａｓ系及び組成物の送達、使用及び治療適用 |
| SG10201913266UA (en) | 2015-12-11 | 2020-02-27 | Massachusetts Eye & Ear Infirmary | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
| WO2017136764A1 (en) * | 2016-02-05 | 2017-08-10 | The General Hospital Corporation | Hybrid system for efficient gene delivery to cells of the inner ear |
| WO2018017834A1 (en) * | 2016-07-21 | 2018-01-25 | The Regents Of The University Of California | Methods for inducing stereocilia on hair cells |
-
2018
- 2018-02-06 WO PCT/US2018/017104 patent/WO2018145111A1/en not_active Ceased
- 2018-02-06 US US16/483,668 patent/US11730827B2/en active Active
- 2018-02-06 AU AU2018215785A patent/AU2018215785B2/en active Active
- 2018-02-06 CA CA3052704A patent/CA3052704A1/en active Pending
- 2018-02-06 EP EP18747407.7A patent/EP3576696A4/en active Pending
- 2018-02-06 JP JP2019542464A patent/JP2020508648A/ja not_active Withdrawn
- 2018-02-06 CN CN201880022337.9A patent/CN111698975A/zh active Pending
-
2023
- 2023-01-04 JP JP2023000088A patent/JP7601916B2/ja active Active
- 2023-07-03 US US18/346,720 patent/US20230330268A1/en active Pending
- 2023-08-09 AU AU2023214288A patent/AU2023214288A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508648A5 (https=) | ||
| PH12020550094A1 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| MX2021011468A (es) | Vectores de virus adenoasociados recombinantes. | |
| Boehler et al. | Lentivirus delivery of IL‐10 to promote and sustain macrophage polarization towards an anti‐inflammatory phenotype | |
| Vannucci et al. | Viral vectors: a look back and ahead on gene transfer technology | |
| CL2019002474A1 (es) | Vector clado f de virus adeno-asociado (vaa) y usos relacionados. | |
| MX2020005451A (es) | Capsides variantes de virus adenoasociados y uso para inhibir la angiogenesis. | |
| EA201991911A1 (ru) | Способы и композиции для переноса генов по сосудистой сети | |
| WO2017058892A3 (en) | Methods and compositions for antibody-evading virus vectors | |
| PH12018502387A1 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| WO2022232327A3 (en) | Aav capsids and uses thereof | |
| MX2020010465A (es) | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| JP2018514190A5 (https=) | ||
| EP4461814A3 (en) | Generation of improved human pah for treatment of severe pku by liver-directed gene replacement therapy | |
| JP2017505626A5 (https=) | ||
| WO2020223362A8 (en) | Compositions useful for treatment of pompe disease | |
| CO2022010227A2 (es) | Proteínas de la cápside de virus adeno-asociados modificadas para la terapia génica ocular y métodos de uso de las mismas | |
| Yoo et al. | M13 bacteriophage and adeno‐associated virus hybrid for novel tissue engineering material with gene delivery functions | |
| MX2023006694A (es) | Tratamiento de la enfermedad de danon. | |
| JP2020533411A5 (https=) | ||
| Dodd et al. | Sustained expression of coagulation factor IX by modified cord blood‐derived mesenchymal stromal cells | |
| JP7711959B2 (ja) | 改変型アデノウイルスヘキソンタンパク質を有するアデノウイルス | |
| Marsch et al. | A novel directed evolution method to enhance cell-type specificity of adeno-associated virus vectors | |
| CN116635523A (zh) | 用于疗法中的rag1的替代物 |